BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51-61. [PMID: 14723996 DOI: 10.1016/S0140-6736(03)15171-9] [Cited by in Crossref: 174] [Cited by in F6Publishing: 42] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Duncan RE, Delatycki MB, Collins SJ, Boyd A, Masters CL, Savulescu J. Ethical considerations in presymptomatic testing for variant CJD. J Med Ethics 2005;31:625-30. [PMID: 16269554 DOI: 10.1136/jme.2005.011965] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Chang B, Miller MW, Bulgin MS, Sorenson-Melson S, Balachandran A, Chiu A, Rubenstein R. PrP antibody binding-induced epitope modulation evokes immunocooperativity. J Neuroimmunol 2008;205:94-100. [PMID: 18977037 DOI: 10.1016/j.jneuroim.2008.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Santa-Cecília FV, Leite CA, Del-Bel E, Raisman-Vozari R. The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases. Neurotox Res 2019;35:981-6. [PMID: 30798507 DOI: 10.1007/s12640-019-00015-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
4 Chi NF, Lee YC, Lu YC, Wu HM, Soong BW. Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol. 2010;257:191-197. [PMID: 19696976 DOI: 10.1007/s00415-009-5290-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
5 Choi B. Studies on Food Safety Knowledge of College Students according to Mass-Media Impact. The Korean Journal of Food And Nutrition 2011;24:166-72. [DOI: 10.9799/ksfan.2011.24.2.166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Falsig J, Nilsson KP, Knowles TP, Aguzzi A. Chemical and biophysical insights into the propagation of prion strains. HFSP J 2008;2:332-41. [PMID: 19436493 DOI: 10.2976/1.2990786] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
7 Martins VR, Gomes HR, Chimelli L, Rosemberg S, Landemberger MC. Prion diseases are undercompulsory notification in Brazil: Surveillance of cases evaluated by biochemicaland/or genetic markers from 2005 to 2007. Dement Neuropsychol 2007;1:347-55. [PMID: 29213410 DOI: 10.1590/S1980-57642008DN10400004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Garske T, Ghani AC. Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 2010;5:e15626. [PMID: 21203419 DOI: 10.1371/journal.pone.0015626] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
9 Lawson VA, Lumicisi B, Welton J, Machalek D, Gouramanis K, Klemm HM, Stewart JD, Masters CL, Hoke DE, Collins SJ, Hill AF. Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein. PLoS One 2010;5:e12351. [PMID: 20808809 DOI: 10.1371/journal.pone.0012351] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
10 Trone-Launer EK, Wang J, Lu G, Mateus-Pinilla NE, Zick PR, Lamer JT, Shelton PA, Jacques CN. Differential gene expression in chronic wasting disease-positive white-tailed deer (Odocoileus virginianus). Ecol Evol 2019;9:12600-12. [PMID: 31788200 DOI: 10.1002/ece3.5724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Sobregrau P, Peri JM, Sánchez del Valle R, Molinuevo JL, Barra B, Pintor L. Psychiatric and Psychosocial Characteristics of a Cohort of Spanish Individuals Attending Genetic Counseling Due to Risk for Genetically Conditioned Dementia. ADR 2022. [DOI: 10.3233/adr-210067] [Reference Citation Analysis]
12 Otero A, Bolea R, Hedman C, Fernández-Borges N, Marín B, López-Pérez Ó, Barrio T, Eraña H, Sánchez-Martín MA, Monzón M, Badiola JJ, Castilla J. An Amino Acid Substitution Found in Animals with Low Susceptibility to Prion Diseases Confers a Protective Dominant-Negative Effect in Prion-Infected Transgenic Mice. Mol Neurobiol 2018;55:6182-92. [PMID: 29264770 DOI: 10.1007/s12035-017-0832-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 Park MJ, Jo HY, Cheon SM, Choi SS, Kim YS, Kim JW. A case of gerstmann-sträussler-scheinker disease. J Clin Neurol 2010;6:46-50. [PMID: 20386644 DOI: 10.3988/jcn.2010.6.1.46] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Forloni G, Tettamanti M, Lucca U, Albanese Y, Quaglio E, Chiesa R, Erbetta A, Villani F, Redaelli V, Tagliavini F, Artuso V, Roiter I. Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases. Prion 2015;9:75-9. [PMID: 25996399 DOI: 10.1080/19336896.2015.1027857] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
15 Na S, Lee SA, Lee JD, Lee ES, Lee TK. Creutzfeldt-Jakob disease presenting with bilateral hearing loss: A case report. World J Clin Cases 2022; 10(18): 6333-6337 [DOI: 10.12998/wjcc.v10.i18.6333] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR, Pai EF, Chakrabartty A. Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci U S A 2010;107:19808-13. [PMID: 21041683 DOI: 10.1073/pnas.1005267107] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
17 Zhang Y, Zhao X, Wang P. Molecular dynamics study of the fibril elongation of the prion protein fragment PrP106–126. Journal of Theoretical Biology 2007;245:238-42. [DOI: 10.1016/j.jtbi.2006.10.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 T Islam AM, Adlard PA, Finkelstein DI, Lewis V, Biggi S, Biasini E, Collins SJ. Acute Neurotoxicity Models of Prion Disease. ACS Chem Neurosci 2018;9:431-45. [PMID: 29393619 DOI: 10.1021/acschemneuro.7b00517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Soubrier M, Haïk S, Hauw JJ, Corvol JC, Lyon-Caen O, Dougados M. Creutzfeldt-Jakob disease in a patient treated by etanercept for rheumatoid arthritis (RA): just a coincidence? Joint Bone Spine 2010;77:174-5. [PMID: 20097590 DOI: 10.1016/j.jbspin.2009.05.016] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Hoppe SO, Uzunoğlu G, Nussbaum-Krammer C. α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies? Biomolecules 2021;11:931. [PMID: 34201558 DOI: 10.3390/biom11070931] [Reference Citation Analysis]
21 Brazier MW, Wedd AG, Collins SJ. Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease. Antioxidants (Basel) 2014;3:288-308. [PMID: 26784872 DOI: 10.3390/antiox3020288] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
22 Otero A, Hedman C, Fernández-Borges N, Eraña H, Marín B, Monzón M, Sánchez-Martín MA, Nonno R, Badiola JJ, Bolea R, Castilla J. A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models. Mol Neurobiol 2019;56:6501-11. [PMID: 30847740 DOI: 10.1007/s12035-019-1535-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Foliaki ST, Lewis V, Islam AMT, Ellett LJ, Senesi M, Finkelstein DI, Roberts B, Lawson VA, Adlard PA, Collins SJ. Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc. PLoS Pathog 2019;15:e1007712. [PMID: 30970042 DOI: 10.1371/journal.ppat.1007712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Haley NJ, Richt JA. Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids. Pathogens 2017;6:E35. [PMID: 28783058 DOI: 10.3390/pathogens6030035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
25 Foliaki ST, Lewis V, Islam AMT, Senesi M, Finkelstein DI, Ellett LJ, Lawson VA, Adlard PA, Roberts BR, Collins SJ. PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity. Biophys J 2020;119:128-41. [PMID: 32562618 DOI: 10.1016/j.bpj.2020.04.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Espinosa JC, Marín-Moreno A, Aguilar-Calvo P, Torres JM. Met166 -Glu168 residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection. Neuropathol Appl Neurobiol 2021;47:506-18. [PMID: 33253417 DOI: 10.1111/nan.12676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Aguzzi A, Heikenwalder M, Miele G. Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. J Clin Invest 2004;114:153-60. [PMID: 15254579 DOI: 10.1172/JCI22438] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
28 Hayashi N, Yagyu Y. Treatment of protein using oxygen plasma produced by RF discharge. Trans Mat Res Soc Japan 2008;33:791-4. [DOI: 10.14723/tmrsj.33.791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
29 Wongchitrat P, Shukla M, Sharma R, Govitrapong P, Reiter RJ. Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection. Antioxidants (Basel) 2021;10:E47. [PMID: 33401749 DOI: 10.3390/antiox10010047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
30 Mori I, Nishiyama Y, Yokochi T, Kimura Y. Olfactory transmission of neurotropic viruses. J Neurovirol 2005;11:129-37. [PMID: 16036791 DOI: 10.1080/13550280590922793] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 6.7] [Reference Citation Analysis]
31 Moore RA, Herzog C, Errett J, Kocisko DA, Arnold KM, Hayes SF, Priola SA. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci 2006;15:609-19. [PMID: 16452616 DOI: 10.1110/ps.051822606] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
32 Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefèvre H, Seifried E, Löwer J. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis 2007;13:89-96. [PMID: 17370520 DOI: 10.3201/eid1301.060396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
33 Collins S, Sarros S. RT-QuIC Assays in Humans … and Animals. Food Saf (Tokyo) 2016;4:115-20. [PMID: 32231915 DOI: 10.14252/foodsafetyfscj.2016020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Sahu S, Sikdar Y, Bag R, Drew MGB, Cerón-Carrasco JP, Goswami S. A Quinoxaline-Naphthaldehyde Conjugate for Colorimetric Determination of Copper Ion. Molecules 2022;27:2908. [PMID: 35566259 DOI: 10.3390/molecules27092908] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13:517-528. [PMID: 27435372 DOI: 10.1038/nrgastro.2016.107] [Cited by in Crossref: 265] [Cited by in F6Publishing: 208] [Article Influence: 44.2] [Reference Citation Analysis]
36 Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. J Biol Chem 2012;287:36465-72. [PMID: 22930754 DOI: 10.1074/jbc.M112.368803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Dagleish MP, Martin S, Steele P, Finlayson J, Eaton SL, Sisó S, Stewart P, Fernández-Borges N, Hamilton S, Pang Y, Chianini F, Reid HW, Goldmann W, González L, Castilla J, Jeffrey M. Susceptibility of European red deer (Cervus elaphus elaphus) to alimentary challenge with bovine spongiform encephalopathy. PLoS One 2015;10:e0116094. [PMID: 25615837 DOI: 10.1371/journal.pone.0116094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
38 Wang KC, Wang V, Sun MC, Chiueh TI, Soong BW, Shan DE. Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan. Eur J Epidemiol 2007;22:257-61. [PMID: 17410475 DOI: 10.1007/s10654-007-9112-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Oliver SP. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Foodborne Pathog Dis 2004;1:65-72. [PMID: 15992264 DOI: 10.1089/153531404772914482] [Reference Citation Analysis]
40 Buono LM. Prion disease. Int Ophthalmol Clin 2007;47:121-9, ix. [PMID: 18049285 DOI: 10.1097/IIO.0b013e318157241a] [Reference Citation Analysis]
41 Davanipour Z, Sobel E, Ziogas A, Smoak C, Bohr T, Doram K, Liwnicz B. Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study. Br J Med Med Res 2014;4:2388-417. [PMID: 24977122 DOI: 10.9734/BJMMR/2014/7209] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Walker LC, Jucker M. Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 2015;38:87-103. [PMID: 25840008 DOI: 10.1146/annurev-neuro-071714-033828] [Cited by in Crossref: 198] [Cited by in F6Publishing: 179] [Article Influence: 28.3] [Reference Citation Analysis]
43 Foliaki ST, Lewis V, Finkelstein DI, Lawson V, Coleman HA, Senesi M, Islam AMT, Chen F, Sarros S, Roberts B, Adlard PA, Collins SJ. Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species. PLoS Pathog 2018;14:e1007214. [PMID: 30089152 DOI: 10.1371/journal.ppat.1007214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
44 Dwivedi S, Purohit P, Misra R, Pareek P, Goel A, Khattri S, Pant KK, Misra S, Sharma P. Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine. Indian J Clin Biochem 2017;32:374-98. [PMID: 29062170 DOI: 10.1007/s12291-017-0688-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
45 Hedlin P, Taschuk R, Potter A, Griebel P, Napper S. Detection and control of prion diseases in food animals. ISRN Vet Sci 2012;2012:254739. [PMID: 23738120 DOI: 10.5402/2012/254739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
46 Yang W, Yang LF, Song ZQ, Shah SZA, Cui YY, Li CS, Zhao HF, Gao HL, Zhou XM, Zhao DM. PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. CNS Neurosci Ther 2017;23:416-27. [PMID: 28294542 DOI: 10.1111/cns.12685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
47 Kang HE, Mo Y, Abd Rahim R, Lee HM, Ryou C. Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion. Biomed Res Int 2017;2017:5413936. [PMID: 28596963 DOI: 10.1155/2017/5413936] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
48 Hayashi N, Nakahigashi A, Liu H, Goto M. Treatment of Second-Order Structures of Proteins Using Oxygen Radio Frequency Plasma. Jpn J Appl Phys 2010;49:08JH02. [DOI: 10.1143/jjap.49.08jh02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Epstein JS, Jaffe HW, Alter HJ, Klein HG. Blood system changes since recognition of transfusion-associated AIDS. Transfusion 2013;53:2365-74. [PMID: 24032622 DOI: 10.1111/trf.12373] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
50 Glynn C, Sawaya MR, Ge P, Gallagher-Jones M, Short CW, Bowman R, Apostol M, Zhou ZH, Eisenberg DS, Rodriguez JA. Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core. Nat Struct Mol Biol 2020;27:417-23. [PMID: 32284600 DOI: 10.1038/s41594-020-0403-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
51 Forloni G, Balducci C. β-amyloid oligomers and prion protein: Fatal attraction? Prion 2011;5:10-5. [PMID: 21150333 DOI: 10.4161/pri.5.1.14367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
52 Fernández MR, Batlle C, Gil-García M, Ventura S. Amyloid cores in prion domains: Key regulators for prion conformational conversion. Prion 2017;11:31-9. [PMID: 28281928 DOI: 10.1080/19336896.2017.1282020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
53 Qing LL, Zhao H, Liu LL. Progress on low susceptibility mechanisms of transmissible spongiform encephalopathies. Dongwuxue Yanjiu 2014;35:436-45. [PMID: 25297084 DOI: 10.13918/j.issn.2095-8137.2014.5.436] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
54 Xia K, Shen H, Wang P, Tan R, Xun D. Investigation of the conformation of human prion protein in ethanol solution using molecular dynamics simulations. J Biomol Struct Dyn 2022;:1-10. [PMID: 35838152 DOI: 10.1080/07391102.2022.2099466] [Reference Citation Analysis]
55 Alsiary RA, Alghrably M, Saoudi A, Al-Ghamdi S, Jaremko L, Jaremko M, Emwas AH. Using NMR spectroscopy to investigate the role played by copper in prion diseases. Neurol Sci 2020;41:2389-406. [PMID: 32328835 DOI: 10.1007/s10072-020-04321-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]